CD8A and breast carcinoma: We demonstrated that the CD169+ cell density and the CD169+/CD68+ macrophage ratio in the RLNs of breast cancer patients correlated with early clinical stage and no LN metastasis as well as with an increased density of CD8+ lymphocytes in cases with a Ki-67 index of >40%.